Published in BMJ on August 07, 1993
Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ (1995) 4.83
Comparison of uptake of breast screening, cervical screening, and childhood immunisation. BMJ (1995) 3.18
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ (1998) 2.61
Response of women aged 65-74 to invitation for screening for breast cancer by mammography: a pilot study in London, UK. J Epidemiol Community Health (1996) 2.61
An economic view of high compliance as a screening objective. BMJ (1994) 2.56
Deprivation and survival from breast cancer. Br J Cancer (1995) 2.27
Monitoring health care in the United States--a challenging task. Public Health Rep (1997) 2.04
Adverse life events and breast cancer: case-control study. BMJ (1995) 1.74
Mammography screening: an incremental cost effectiveness analysis of double versus single reading of mammograms. BMJ (1996) 1.70
What general practitioners should do about breast screening. BMJ (1995) 1.65
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer (1994) 1.65
Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London. J Epidemiol Community Health (1995) 1.54
Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland. Br J Cancer (2011) 1.54
Opinion: why the variation in breast cancer survival in Europe? Breast Cancer Res (1999) 1.26
Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health (1996) 1.07
Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer (1995) 1.02
Screening for breast cancer. Screening programme not cost effective. BMJ (1994) 0.99
Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme. Br J Cancer (1996) 0.98
Screening for breast cancer. Mammography unsafe and unreliable. BMJ (1993) 0.97
Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany. J Epidemiol Community Health (1997) 0.91
Screening for breast cancer. BMJ (1994) 0.87
Breast screening: a randomised controlled trial in UK general practice of three interventions designed to increase uptake. J Epidemiol Community Health (1996) 0.83
A comparative audit of prevalent, incident and interval cancers in the Avon breast screening programme. Ann R Coll Surg Engl (1997) 0.80
Screening for breast cancer. Discrepancies in studies are confusing. BMJ (1994) 0.75
Prevalence study of carcinoma in situ of testis in oligozoospermic men. Study was too small to show potential benefits of screening. BMJ (1998) 0.75
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat (1991) 4.46
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet (1996) 20.53
Zebrafish informatics and the ZFIN database. Methods Cell Biol (1999) 16.45
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet (2005) 6.18
Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet (1990) 6.17
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet (1999) 4.80
Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet (1989) 4.72
Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol (1989) 4.07
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
The efficacy of double reading mammograms in breast screening. Clin Radiol (1994) 2.60
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut (1999) 2.53
An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model. J Epidemiol Community Health (1986) 2.02
The Edinburgh randomised trial of screening for breast cancer: description of method. Br J Cancer (1984) 1.93
Oral cancer in the UK: to screen or not to screen. Oral Oncol (1998) 1.91
Adverse life events and breast cancer: case-control study. BMJ (1995) 1.74
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut (2011) 1.67
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer (1994) 1.65
Results from the NHS breast screening programme 1990-1993. J Med Screen (1995) 1.64
Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales. Br J Urol (1997) 1.63
A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme. J Med Screen (1998) 1.57
Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland. Br J Cancer (2011) 1.54
Stereotaxic localisation and aspiration cytology of impalpable breast lesions. Clin Radiol (1989) 1.51
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer (2006) 1.48
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magn Reson Imaging (2000) 1.47
Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer (1991) 1.42
Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol (1990) 1.36
Localization and excision of occult breast lesions. Br J Surg (1983) 1.34
Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in England. Endoscopy (2012) 1.31
Results from the UK NHS breast screening programme 1994-1999. J Med Screen (2000) 1.24
Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer (2011) 1.22
A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. J Epidemiol Community Health (1988) 1.15
Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate. J Med Screen (1996) 1.15
Monitoring the ERSPC trial. BJU Int (2003) 1.13
Acute inflammation of the breast--the role of breast ultrasound in diagnosis and management. Clin Radiol (1991) 1.12
Emboli enter penetrating arteries of monkey brain in relation to their size. Stroke (1995) 1.11
HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study. Br J Cancer (2011) 1.10
Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme. Br J Radiol (1997) 1.09
Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol (2004) 1.07
The diagnosis, management, treatment and costs of prostate cancer in England and Wales. Health Technol Assess (1997) 1.06
Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years. Br J Cancer (2005) 1.03
Promoting early presentation of breast cancer: development of a psycho-educational intervention. Chronic Illn (2008) 1.03
Breast self-examination programmes in the trial of early detection of breast cancer: ten year findings. Br J Cancer (1993) 1.03
Results from the UK NHS Breast Screening Programme 2000-05. J Med Screen (2007) 1.01
Rapidly progressive cervical cancer: is it a real problem? Br J Obstet Gynaecol (1988) 0.99
Effect of retesting with dietary restriction in Haemoccult screening for colorectal cancer. J Med Screen (1995) 0.95
Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. J Psychiatr Res (2010) 0.94
Liver abnormalities associated with chronic mercury accumulation in stranded Atlantic bottlenose dolphins. Ecotoxicol Environ Saf (1993) 0.93
Monitoring and evaluating the UK National Health Service Breast Screening Programme: evaluating the variation in radiological performance between individual programmes using PPV-referral diagrams. J Med Screen (2001) 0.93
Binding and uptake of native and glycosylated albumin-gold complexes in perfused rat lungs. Microvasc Res (1986) 0.92
Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer. Eur J Cancer (1993) 0.92
Impact of skin cancer education on general practitioners' diagnostic skills. Clin Exp Dermatol (2000) 0.90
The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). J Exp Clin Cancer Res (2002) 0.90
Lung cancer screening: improved survival but no reduction in deaths--the role of "overdiagnosis". Cancer (2000) 0.89
Systemic mycosis due to Aspergillus deflectus in a dog. Aust Vet J (2000) 0.89
An observational study to evaluate the performance of units using two radiographers to read screening mammograms. Clin Radiol (2011) 0.89
Does individual programme size affect screening performance? Results from the United Kingdom NHS breast screening programme. J Med Screen (2002) 0.89
Oblique-view mammography: adequacy for screening. Work in progress. Radiology (1984) 0.88
Monitoring the performance of breast screening programmes: allowing for geographical variation in breast cancer incidence. J Med Screen (1996) 0.87
Cooling the burn wound to maintain microcirculation. J Trauma (1981) 0.87
Observer variability in the histopathological reporting of abnormal rectal biopsy specimens. J Clin Pathol (1994) 0.87
Breast cancer screening: an appraisal. Clin Radiol (1991) 0.87
Inferior vena caval thrombosis complicating acute pancreatitis. Case report. Acta Chir Scand (1988) 0.86
PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer. Eur J Cancer (2010) 0.86
Assessment of non-palpable mammographic abnormalities: comparison between screening and symptomatic clinics. Br J Surg (1992) 0.86
Detailed monitoring of the effects of mannitol following experimental head injury. J Neurosurg (1979) 0.86
Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. Breast (2000) 0.86
Efficiency of cancer detection during routine repeat (incident) mammographic screening: two versus one view mammography. J Med Screen (1998) 0.85
Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg (1995) 0.85
The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk. Br J Cancer (2006) 0.85
Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics (1984) 0.84
Tuberculous epididymo-orchitis: clinical and ultrasound observations. Br J Urol (1989) 0.84
An unusual case of an enlarging mass on a screening mammogram: a case report and review of the radiology and current literature. Breast (2003) 0.84
Synthesis of murine leukemia virus in cell culture. Int J Cancer (1973) 0.84
The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates. Clin Radiol (2005) 0.83
Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening. Br J Surg (1999) 0.83
Randomized comparison of Guglielmi detachable coils and cellulose acetate polymer for treatment of aneurysms in dogs. Stroke (1998) 0.83
Screening outcomes in women over age 70 who self-refer in the NHSBSP in England. J Med Screen (2011) 0.83
Selective contracting in California: early effects and policy implications. Inquiry (1985) 0.83
Breast carcinoma mortality rates and screening. Cancer (1997) 0.83
Faecal occult blood screening for colorectal cancer. J Med Screen (2002) 0.82
The sympathetic nervous system and atherosclerosis. J Neurosurg (1987) 0.82
Non-Hodgkin's lymphoma confined to the adrenal glands presenting with Addison's disease. Clin Radiol (1990) 0.82
Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance. J Med Screen (2010) 0.82
Subarachnoid hemorrhage as a cause of an adaptive response in cerebral arteries. J Neurosurg (2000) 0.82
Early rescreen/recall in the UK National Health Service breast screening programme: epidemiological data. J Med Screen (1998) 0.81
Developing capacities of youth as lay health advisors: a case study with high school students. Health Educ Behav (1997) 0.81
Outcome of surgery for non-palpable mammographic abnormalities. Br J Surg (1990) 0.81
Papaverine-sensitive vasospasm and arterial contractility and compliance after subarachnoid hemorrhage in dogs. Neurosurgery (1995) 0.81
Selective contracting in California: experience in the second year. Inquiry (1985) 0.81
Selective contracting in California: an update. Inquiry (1989) 0.81
Lipiodol enhanced CT scanning in assessment of hepatocellular carcinoma. Clin Radiol (1989) 0.81
Heme oxygenase-1 and ferritin are increased in cerebral arteries after subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab (2000) 0.81
Risk of cervical abnormality after age 50 in women with previously negative smears. Br J Cancer (2009) 0.80
Evaluation of extension of breast screening to women aged 65-70 in England using screening performance measures. Br J Cancer (2009) 0.80
Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process. J Med Screen (2000) 0.79
Microcalcification and its relationship to cancer of the breast: experience in a screening clinic. Clin Radiol (1983) 0.79